Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Honest Company Inc (HNST) vs Smith & Nephew plc (SNN) Price & Performance

Honest Company IncTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Honest Company Inc vs Smith & Nephew plc — how do they compare? Honest Company Inc trades at $3.89 (market cap $426.55M), while Smith & Nephew plc trades at $30.16 (market cap $12.64B). The key difference: Smith & Nephew plc is far larger — about 29.6× Honest Company Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals.

HNSTSNN
Market Cap
$426.55M$12.64B
Sector
Consumer StaplesHealth
52-Week High
$4.95$38.70
52-Week Low
$2.10$28.73
Enterprise Value
$347.95M$15.41B
Dividend Yield
2.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Honest Company Inc

HNST trades at $3.87, up 1.04% today, with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $0.01, meeting estimates, but has missed expectations in two of the last three quarters. Revenue declined to $371.32 million in 2025 from $378 million in 2024, with a net loss of $15.69 million. Positive cash flow from operations of $15.12 million and record gross margins near 34% highlight operational improvements amid challenges.

The outlook remains mixed; analyst consensus is cautious with 30% buy ratings. Upside potential exists from gross margin expansion and cost controls, but risks include persistent net losses, competitive pressures in personal care, and reliance on retail channel growth. Investor sentiment is neutral, pending sustained profitability and revenue stabilization in 2026.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.43, down 0.54% on the day, with mixed technical signals showing a neutral overall stance. The company demonstrates improving fundamentals with 2024 revenue of $5.81 billion and net income of $412 million, representing a 7.09% margin. Recent product launches including the LYNX COBLATION Wand and CORI XT robotics platform highlight ongoing innovation. Cash flow trends show strong operational performance with $987 million from operations in 2024.

SNN presents a balanced investment case with improving profitability and product innovation offset by recent earnings misses. The stock trades at reasonable valuations (P/E 21.36, P/S 2.17) with analyst consensus leaning Hold (68%). Key risks include execution challenges and competitive pressures, while catalysts include robotics expansion and wound care leadership. The $500 million buyback program supports shareholder returns.

Returns comparison

Trailing returns across standard periods

About Honest Company Inc

The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.

Read more on HNST

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN